From the FCCDC website:
http://www.fc-cdci.com/PressReleases/2018-09-05_DoD.html
IMO, this has to show some advancement has been shown by FCCDC regarding work into B-Fungal for them to have come to commercialization terms of payment. May have a bit more legs than what one would think at first blush.
Also, the VP - Research (Dr Richard Scott) at FCCDC is one of the developers of Brilacidin from the U of Penn days/Polymedix
http://www.fc-cdci.com/PressReleases/2018-09-05_DoD.html
IMO, this has to show some advancement has been shown by FCCDC regarding work into B-Fungal for them to have come to commercialization terms of payment. May have a bit more legs than what one would think at first blush.
Also, the VP - Research (Dr Richard Scott) at FCCDC is one of the developers of Brilacidin from the U of Penn days/Polymedix
10